Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi: Our Bureau, Mumbai Friday, April 4, ...

Helsinn Group submits new innovative formulation of Akynzeo to European Medicines Agency: Lugano, Switzerland Friday, April 4, 2025, 17:00 Hrs [IST] Helsinn Group, a global pharma ...

Sova Health launches advanced microbiome tests & evidence-based precision supplements: Our Bureau, Bengaluru Friday, April 4, 2025, 16:50 Hrs [IST] Sova Health, India’s first fu ...

Aon reports rising healthcare costs with India among the fastest-growing medical markets: Our Bureau, Bengaluru Friday, April 4, 2025, 16:40 Hrs [IST] Aon’s Global Medical Trend ...

San Diego, California Friday, April 4, 2025, 16:00 Hrs [IST] ...

Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...

Medical PG and PhD educators urge NMC to reverse discriminatory policy: Our Bureau, New Delhi Friday, April 4, 2025, 08:00 ...

US FDA grants orphan drug designation to Sanofi’s rilzabrutinib, an oral, reversible BTK inhibitor for two rare diseases: Paris Friday, April 4, 2025, 14:00 Hrs [IST] The US Foo ...

MultiOmic Health inks MoU with Alloy Therapeutics to discover and develop renal tissue-targeting drugs: London Friday, April 4, 2025, 13:00 Hrs [IST] MultiOmic Health Limited, an ...

CHMP recommends approval for Averoa’s Xoanacyl, an oral therapy for chronic kidney disease: Grenoble, France Friday, April 4, 2025, 12:00 Hrs [IST] Averoa, a biopharmaceutical c ...

Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint: Basel Friday, April 4, 2025, 11:00 Hrs [IST] Roc ...

Basel, Switzerland Friday, April 4, 2025, 10:00 Hrs [IST] ...